Skip to content

probiotics and prediabetes

Effect of probiotic supplementation on glycemic, inflammatory indices, blood lipids and body composition in prediabetic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013022411763N5
Enrollment
60
Registered
2013-08-06
Start date
2012-12-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prediabetes. Non-insulin-dependent diabetes mellitus

Interventions

Sponsors

Vice Chancellor for Research, Isfahan University of Medical Sciences
Lead Sponsor
Research Deputy of Isfahan University of Medical Sciences
Collaborator

Eligibility

Sex/Gender
All
Age
25 Years to 65 Years

Inclusion criteria

Inclusion criteria: all prediabetic patients at the age range of 25 to 65 years old with fsting plasma glucose between 100 and 125 mg/dl and glucose tolerance test between 140 to 200 mg/dl are included in the study, study subjects must have an stesdy state of glycemic and lipid control and drug usage. patients with chronic hepatic, renal, heart and acute inflammatory diseases are not included in the study. patients who have allergic responses to probiotics or those who want to give up following the study or those who have not taken their probiotics will be excluded from the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose. Timepoint: the first day of the study and the last day of 8th week. Method of measurement: Colorimetry.;Glycated hemoglobin(HbA1C). Timepoint: the first day of the study and the last day of 8th week. Method of measurement: Ion exchange chromatography.;Total serum cholestrol. Timepoint: the first day of the study and the last day of 8th week. Method of measurement: Enzymatic assay with autoanalyser.;Serum triglycerides. Timepoint: the first day of the study and the last day of 8th week. Method of measurement: Enzymatic assay with autoanalyser.;Serum low density lipoprotein. Timepoint: the first day of the study and the last day of 8th week. Method of measurement: Enzymatic assay with autoanalyser.;Serum High density lipoprotein. Timepoint: The first day of the study and the last day of 8th week. Method of measurement: Enzymatic assay with autoanalyser.;Erythrocyte sedimentation rate. Timepoint: The first day of the study and the last day of 8th week. Method of measurement: Instrumental analaysis method.;High sensitive C- Reactive Protein. Timepoint: The first day of the study and the last day of 8th week. Method of measurement: Turbidimetric Method.

Secondary

MeasureTime frame
Height. Timepoint: The first day of the study and the last day of 8th week. Method of measurement: Stadiometer.;Body compisition. Timepoint: the first day of the study and the last day of 8th week. Method of measurement: BIA method.;Blood pressure. Timepoint: The first day of the study and the last day of 8th week. Method of measurement: Presure indicator.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSepideh.Mahboobi

Isfahan University Of Medical Sciences

sepidmahboobi@gmail.com+98 31 1792 2110

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026